Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

Cited by (870)

Items 501–600 of 870

1. Reliability and validity of the French-Canadian Late Life Function and Disability Instrument in community-living wheelchair-users
   Brodie M. Sakakibara, François Routhier, Marie-Pier Lavoie, William Cameron Miller · 2013 · Scandinavian Journal of Occupational Therapy
2. Interventions to reduce experiences of stigma and discrimination of people with mental illness and their caregivers
   Roland Brian Büchter, Dawid Pieper, Erin Ueffing, Beate Zschorlich · 2013 · Cochrane Database of Systematic Reviews
3. Cognitive behaviour therapy versus standard care for schizophrenia
   Chris Jones, Colin Campbell, Irene Cormac, David Hacker, Alan Meaden · 2009 · Cochrane Database of Systematic Reviews
4. Reliability and Validity Testing of Wagnild and Young’s Resilience Scale in a Sample of Nigerian Youth
   Samuel Ekundayo Oladipo, Erhabor Sunday Idemudia · 2015 · Journal of Psychology
5. Fluphenazine (oral) versus placebo for schizophrenia
   Hosam E. Matar, Muhammad Qutayba Almerie, Stephanie J Sampson · 2018 · Cochrane Database of Systematic Reviews
6. Benperidol for schizophrenia
   Christian J. Schwarz, Benno Hartung, Stefan Leucht · 2005 · Cochrane Database of Systematic Reviews
7. Preventive interventions for postnatal psychosis
   Adib Essali, Samer Alabed, Aisha Guul, Norah Essali · 2013 · Cochrane Database of Systematic Reviews
8. Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
   Heather L. Bowling, Emanuela Santini · 2016 · Swiss Medical Weekly
9. Sulpiride augmentation for schizophrenia
   Jijun Wang, Ichiro M Omori, Mark Fenton, Bernardo GO Soares · 2009 · Cochrane Database of Systematic Reviews
10. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
    Anitha Mukundan, Guy Faulkner, Tony A. Cohn, Gary J. Remington · 2007 · Cochrane Database of Systematic Reviews
11. Pharmacological treatments for psychosis-related polydipsia
    Guy Brookes, AG Ahmed · 2002 · Cochrane Database of Systematic Reviews
12. Pharmacological interventions for clozapine-induced sinus tachycardia
    John Lally, Mary Jane Docherty, James Hunter MacCabe · 2015 · Cochrane Database of Systematic Reviews
13. Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis
    Susanna Franziska Mayer, Ciarán Corcoran, Liam Kennedy, Stefan Leucht, Irene Bighelli · 2024 · Cochrane Database of Systematic Reviews
14. Cognitive behavioural therapy without medication for schizophrenia
    Irene Bighelli, Oğulcan Çıray, Nurul Husna Salahuddin, Stefan Leucht · 2024 · Cochrane Database of Systematic Reviews
15. Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia
    Christopher Allen Jones, Irene Cormac, Colin Campbell, Alan Meaden, David Hacker · 2009 · Cochrane Database of Systematic Reviews
16. Pharmacological interventions for prevention of weight gain in people with schizophrenia
    Sri Mahavir Agarwal, Zohra A Ahsan, Jonathan Lockwood, Markus J. Duncan, Hiroyoshi Takeuchi, Tony A. Cohn, Valerie H. Taylor, Gary J. Remington, Guy Faulkner, Margaret Hahn · 2019 · Cochrane Database of Systematic Reviews
17. Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis
    Spyridon Siafis, Giacomo Deste, Anna Ceraso, Christian Mussoni, Antonio Vita, Senad Hasanagić, Johannes Schneider‐Thoma, Georgios Papazisis, John M. Davis, Stefan Leucht · 2019 · Psychological Medicine
18. Pharmacological interventions for self-harm in adults
    Katrina Witt, Keith E Hawton, Sarah Elisabeth Hetrick, Tatiana Taylor Salisbury, Ellen Townsend, Philip Hazell · 2020 · Cochrane Database of Systematic Reviews
19. Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Markus Dold, Rolf R. Engel, Stefan Leucht · 2014 · Cochrane Database of Systematic Reviews
20. Bromperidol decanoate (depot) for schizophrenia
    Marianna Purgato, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews
21. Selective noradrenaline reuptake inhibitors for schizophrenia
    Paul Matthews, Jamie Horder, Michael J. Pearce · 2018 · Cochrane Database of Systematic Reviews
22. Haloperidol (rapid tranquilisation) for psychosis induced aggression or agitation
    Melanie J Powney, Clive Elliott Adams, Hannah Grace Jones · 2011 · Cochrane Database of Systematic Reviews
23. An Argument for Conducting Methodologically Strong, Randomized, Controlled Trials in Educational Research
    John Coverdale, Richard Balon, Eugene V. Beresin, Alan K. Louie, Glendon R. Tait, Laura Weiss Roberts · 2013 · Academic Psychiatry
24. Getting to grips with hand eczema: measuring skin disease severity objectively
    Carolyn R. Charman, John S. C. English · 2005 · British Journal of Dermatology
25. Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf R. Engel, Markus Dold, Werner Kissling · 2011 · Cochrane Database of Systematic Reviews
26. Risperidone versus olanzapine for schizophrenia
    Mahesh Jayaram, Prakash Hosalli · 2005
27. Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
    Jacqueline Sin, Debbie Spain, Marie Furuta, Trevor Murrells, Ian James Norman · 2015 · Cochrane Database of Systematic Reviews
28. Fluphenazine (oral) versus placebo for schizophrenia
    Hosam E. Matar, Muhammad Qutayba Almerie · 2007 · Cochrane Database of Systematic Reviews
29. The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients – A systematic review and meta-analysis of randomized controlled trials
    Laurent Béchard, Charles Desmeules, Lauryann Bachand, Maxime Huot‐Lavoie, Olivier Corbeil, Elizabeth L. Anderson, Sébastien Brodeur, Annie LeBlanc, Marie‐France Demers, Sophie Lauzier et al. · 2024 · European Psychiatry
30. Acetophenazine versus chlorpromazine for schizophrenia
    Azam Bazrafshan, Morteza Zare, Maryam Okhovati, Manzumeh Shamsi Meymandi · 2015 · Cochrane Database of Systematic Reviews
31. The construct validity of an abridged version of the general self-efficacy scale for adults with attention-deficit/hyperactivity disorder
    Tatiana Skliarova, Henrik Pedersen, Hege Hafstad, Jonas Rennemo Vaag, Mariela Loreto Lara‐Cabrera, Audun Havnen · 2023 · Frontiers in Psychiatry
32. Physical activity for treatment of irritable bowel syndrome
    David Nunan, Joanna Boughtflower, Nia Wyn Roberts, Kamal Ram Mahtani · 2015 · Cochrane Database of Systematic Reviews
33. Aripiprazole for psychosis-induced aggression or agitation
    Bhuvaneshwar Pagadala, Mahesh Jayaram, Lopamudra Mitra · 2009 · Cochrane Database of Systematic Reviews
34. Cognitive behaviour therapy (group) for schizophrenia
    Giuseppe Guaiana, Anna Clara Morelli, Debbie Chiodo · 2012 · Cochrane Database of Systematic Reviews
35. Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia
    Karen Morris, Graeme S. Reid, Sally Spencer · 2018 · Cochrane Database of Systematic Reviews
36. Chlorpromazine versus piperacetazine for schizophrenia
    Mahin Eslami Shahrbabaki, Reza Dehnavieh, Leila Vali, Rahim Sharafkhani · 2018 · Cochrane Database of Systematic Reviews
37. The benefits and threats of research partnerships with industry
    G. Duval · 2005 · Critical Care
38. Development of a Danish Language Version of the Manchester Foot Pain and Disability Index: Reproducibility and Construct Validity Testing
    Christian Korsgaard Pedersen, Bente Danneskiold‐Samsøe, Adam P. Garrow, Eva Ejlersen Wæhrens, Henning Bliddal, Robin Christensen, Else Marie Bartels · 2013 · Pain Research and Treatment
39. Metastatic colorectal cancer: treatment challenges and quality of life
    Andrew Bottomley · 2002 · The Lancet
40. Yoga as part of a package of care versus non-standard care for schizophrenia
    Julie M. Broderick, Davy Vancampfort · 2019 · Cochrane Database of Systematic Reviews
41. Exercise therapy for schizophrenia
    Paul Campbell, DAVID R. FOXCROFT · 2003 · Cochrane Database of Systematic Reviews
42. Flupenthixol versus placebo for schizophrenia
    Xiaohong Shen, Jun Xia, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews
43. Pharmacological treatment for antipsychotic-related constipation
    Susanna Every‐Palmer, Giles Newton‐Howes, Mike J Clarke · 2014 · Cochrane Database of Systematic Reviews
44. Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf R. Engel, Maximilian Huhn, Werner Kissling · 2011 · Cochrane Database of Systematic Reviews
45. Quetiapine versus typical antipsychotic medications for schizophrenia
    Sirijit Suttajit, Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Siritree Suttajit · 2009 · Cochrane Database of Systematic Reviews
46. Quetiapine versus other atypical antipsychotics for schizophrenia
    Katja Komossa, Heike Hunger, Franziska Schmidt, Sandra Schwarz, Stefan Leucht, Manit Srisurapanont, Christine Rummel‐Kluge · 2007 · Cochrane Database of Systematic Reviews
47. Smoking cessation advice for people with serious mental illness
    Priya Khanna, Andrew Clifton, David Banks, Graeme E Tosh · 2012 · Cochrane Database of Systematic Reviews
48. Training to recognise the early signs of recurrence in schizophrenia
    Richard Keith Morriss, Catherine A Bolton, Mohammad Amir Faizal, Max Marshall, James P. McCarthy · 2004 · Cochrane Database of Systematic Reviews
49. Yoga as part of a package of care versus standard care for schizophrenia
    Julie M. Broderick, Niall Crumlish, Davy Vancampfort · 2016 · Cochrane Database of Systematic Reviews
50. Targeted psychological and psychosocial interventions for auditory hallucinations in persons with psychotic disorders: Protocol for a systematic review and meta-analysis
    Laura Fässler, Irene Bighelli, Stefan Leucht, Michel Sabé, Malek Bajbouj, Christine Knaevelsrud, Kerem Böge · 2024 · PLoS ONE
51. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
    Irene Bighelli, Myrto T. Samara, Alessandro Rodolico, Wulf‐Peter Hansen, Stefan Leucht · 2021 · Cochrane Database of Systematic Reviews
52. Interventions for obsessive compulsive symptoms in people with schizophrenia
    Mohan Raj, Saeed Farooq · 2005 · Cochrane Database of Systematic Reviews
53. Sulpiride versus other antipsychotics for schizophrenia
    Ichiro M Omori, Jijun Wang, Bernardo GO Soares, Mark Fenton · 2009 · Cochrane Database of Systematic Reviews
54. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia
    Hany George G El-Sayeh, John Rathbone, Karla Soares‐Weiser, Hanna Bergman · 2018 · Cochrane Database of Systematic Reviews
55. Family-based interventions versus standard care for people with schizophrenia
    Wai Tong Chien, Chak Fai Ma, Daniel Thomas Bressington, Lorna Kwai Ping Suen · 2020 · Cochrane Database of Systematic Reviews
56. Planning a clinical research study
    Mohit Bhandari, Simon Chan, Anders Jonsson · 2007 · Indian Journal of Orthopaedics
57. Ontology, Measurement, and Other Fundamental Problems of Scientific Inference
    Kristian E. Markon · 2015 · Psychological Inquiry
58. Group psychoeducation for forensic long-term patients with schizophrenia
    Kati Aho‐Mustonen · 2011 · UEF eRepo (University of Eastern Finland)
59. Antipsychotic combinations for schizophrenia
    Nicola Maayan, Karla Soares‐Weiser, Jun Xia, Clive Elliott Adams · 2011 · Cochrane Database of Systematic Reviews
60. Testosterone for schizophrenia
    Alby Elias, Ajit Kumar · 2006 · Cochrane Database of Systematic Reviews
61. Psychoeducation for siblings of people with severe mental illness
    Jacqueline Sin, Cheryl Jordan, Elizabeth Alexandra Barley, Claire Henderson, Ian James Norman · 2013 · Cochrane Database of Systematic Reviews
62. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Werner Kissling, Rolf R. Engel, Maximilian Huhn, Katja Komossa · 2011 · Cochrane Database of Systematic Reviews
63. Zotepine versus placebo for schizophrenia
    Rebecca Dickenson, Mark Fenton · 2013 · Cochrane Database of Systematic Reviews
64. Clozapine augmentation for treatment-resistant schizoaffective disorder
    John Lally, John Tully, James Hunter MacCabe · 2016 · Cochrane Database of Systematic Reviews
65. Clozapine versus olanzapine for people with schizophrenia
    Claudia Asenjo Lobos, Carolina Fonseca, Stefan Leucht, Marcelo Arancibia M, Marcela Cortés-Jofré · 2018 · Cochrane Database of Systematic Reviews
66. Treatments for primary delusional infestation
    Iyas Assalman, Anthony Bewley, Randa Alhajjar, Alia Ahmed, Ruth E. Taylor · 2014 · Cochrane Database of Systematic Reviews
67. Avatar therapy for schizophrenia or related disorders
    Mahdi Moazzen, Farhad Shokraneh · 2015 · Cochrane Database of Systematic Reviews
68. Early interventions for prodromal stage of psychosis
    Dina Bošnjak, Ivana Kekin, Joanne Hew, Martina Rojnić Kuzman · 2016 · Cochrane Database of Systematic Reviews
69. Specialised early intervention teams for first episode psychosis
    Stephen Puntis, Amedeo Minichino, Franco De Crescenzo, Andrea Cipriani, Belinda Lennox · 2019 · Cochrane Database of Systematic Reviews
70. Complete and transparent reporting of primary end points of randomized trials in the dermatology literature: A comparison of registered and published primary end points
    D.Y. Kim, Sohee Oh, Hyun‐Sun Yoon · 2020 · Journal of the American Academy of Dermatology
71. Client feedback in psychological therapy for children and adolescents with mental health problems
    Hege Kornør, Hanna Bergman, Ketil Hanssen‐Bauer, Karla Soares‐Weiser, Thomas Kristian Tollefsen, Arild Bjørndal · 2015 · Cochrane Database of Systematic Reviews
72. Development and validation of Ayurveda based assessment scale for anxiety
    Basavaraj R. Tubaki, Gandhidas S. Lavekar, C.R. Chandrashekar, Talakad Narasappa Sathyaprabha, Bindu M. Kutty · 2023 · Journal of Ayurveda and Integrative Medicine
73. Developing a Reporting Guideline for Social and Psychological Intervention Trials
    Paul Montgomery, Sean Grant, Sally Hopewell, Geraldine M. Macdonald, David Moher, Evan Mayo‐Wilson · 2013 · The British Journal of Social Work
74. Meta-analysis: A 12-step program
    L. Streiner David · 2003 · Journal of Gambling Issues
75. Chlorpromazine versus reserpine for schizophrenia
    Selin Nur, Clive Elliott Adams · 2016 · Cochrane Database of Systematic Reviews
76. Oral health advice for people with serious mental illness
    Waqqas Ahmad Khokhar, Mohammed Mubashir Mazhar Imran Ali, Hannah Grace Jones, Andrew Clifton, Graeme E Tosh · 2010 · Cochrane Database of Systematic Reviews
77. Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic pain
    Farzaneh Alebouyeh, Isabelle Boutron, Philippe Ravaud, Viet-Thi Tran · 2024 · Journal of Clinical Epidemiology
78. Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis
    Spyridon Siafis, Carolin Lorenz, Hui Wu, Yikang Zhu, Johannes Schneider‐Thoma, Irene Bighelli, Chunbo Li, Wulf‐Peter Hansen, Frank Padberg, Georgia Salanti et al. · 2024 · Systematic Reviews
79. Systematic Review of Measurement Property Evidence for 8 Financial Management Instruments in Populations With Acquired Cognitive Impairment
    Lisa Engel, Adora Chui, Dorcas Beaton, Robin Green, DEIRDRE R. DAWSON · 2018 · Archives of Physical Medicine and Rehabilitation
80. Specialised early intervention teams (extended time) for first episode psychosis
    Stephen Puntis, Amedeo Minichino, Franco De Crescenzo, Andrea Cipriani, Belinda Lennox · 2019 · Cochrane Database of Systematic Reviews
81. Magnetic seizure therapy for people with schizophrenia
    Hui Wu, Jiangling Jiang, Xinyi Cao, Jijun Wang, Chunbo Li · 2023 · Cochrane Database of Systematic Reviews
82. Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia
    Javier Ballesteros, María Concepción Moreno-Calvete, Borja Santos‐Zorrozúa, Eduardo González–Fraile · 2023 · Cochrane Database of Systematic Reviews
83. Pharmacological interventions for reducing weight gain in schizophrenia
    Margaret Hahn, Gary J. Remington, Markus J. Duncan, Tony A. Cohn, Guy Faulkner · 2014 · Cochrane Database of Systematic Reviews
84. Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia
    Adib Essali, ANAS RIHAWI, Mohammad Altujjar, Bishr Alhafez, Amjad Tarboush, Nahla Alhaj Hasan · 2013 · Cochrane Database of Systematic Reviews
85. Brief Family Intervention for Schizophrenia
    Uzuazomaro Okpokoro, S. Sampson · 2014 · Schizophrenia Bulletin
86. Bifeprunox versus placebo for schizophrenia
    Arka Chattopadhyay, Stephen Frey, Ghiselle Green · 2016 · Cochrane Database of Systematic Reviews
87. Quetiapine dose for people with schizophrenia
    Yousaf Iqbal, Chris Connell, Mark Worthington, Heba Elrafei, Caroline A. Mulvaney, Christina Kaewchaluay · 2019 · Cochrane Database of Systematic Reviews
88. STEM education in elementary grades: design of an effective framework for improving attitudes towards school science
    Radu Bogdan Toma · 2020
89. Paliperidone for schizophrenia
    Abraham M. Nussbaum, ST Stroup · 2007 · Cochrane Database of Systematic Reviews
90. Supportive therapy for schizophrenia
    LA Buckley, Tor ACL Pettit · 2007 · Cochrane Database of Systematic Reviews
91. Clotiapine for acute psychotic illnesses
    Simone Carpenter, M Berk · 2001
92. De-escalation techniques for psychosis-induced aggression or agitation
    Harish Rao, Wan-Ley Yeung, Mahesh Jayaram · 2012 · Cochrane Database of Systematic Reviews
93. Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf R. Engel, Maximilian Huhn, Werner Kissling · 2011 · Cochrane Database of Systematic Reviews
94. Risperidone dose for schizophrenia
    Chunbo Li, Jun Xia, Jijun Wang · 2008 · Cochrane Database of Systematic Reviews
95. Haloperidol for long-term aggression in psychosis
    Abha Khushu, Melanie J Powney, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews
96. Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Stefan Leucht, Andrey Potapov, Rolf R. Engel, Markus Dold, Werner Kissling · 2011 · Cochrane Database of Systematic Reviews
97. Social skills programmes for schizophrenia
    Muhammad Qutayba Almerie, Muhammad Okba Al Marhi, Mohamad Alsabbagh, Muhammad Jawoosh, Hosam E. Matar, Nicola Maayan · 2011 · Cochrane Database of Systematic Reviews
98. Yoga versus non-standard care for schizophrenia
    Julie M. Broderick, Niall Crumlish, Alice Waugh, Davy Vancampfort · 2016 · Cochrane Database of Systematic Reviews
99. Wendan decoction (Traditional Chinese medicine) for schizophrenia
    Hongyong Deng, Ji Xu · 2016 · Cochrane Database of Systematic Reviews
100. French-language questionnaires in ENT: Inventory and review
     Stéphane Gargula, E. Babin, Maria‐Pia Tuset, Mary Daval, A. Mattei, D. Ayache · 2024 · European Annals of Otorhinolaryngology Head and Neck Diseases